Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.
Open | $23.560 |
Close | $24.490 |
Volume / Avg. | 817.338K / 501.822K |
Day Range | 23.140 - 24.620 |
52 Wk Range | 23.140 - 35.560 |
Market Cap | $1.178B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 20.17% |
Days to Cover | 15.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mirum Pharmaceuticals (NASDAQ: MIRM) through any online brokerage.
Other companies in Mirum Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).
The latest price target for Mirum Pharmaceuticals (NASDAQ: MIRM) was reported by Stifel on Wednesday, April 17, 2024. The analyst firm set a price target for 48.00 expecting MIRM to rise to within 12 months (a possible 92.00% upside). 32 analyst firms have reported ratings in the last year.
The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $25 last updated April 25, 2024 at 7:26 PM EDT.
There are no upcoming dividends for Mirum Pharmaceuticals.
Mirum Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Mirum Pharmaceuticals.
Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.